Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice
Open Access
- 14 July 2010
- journal article
- Published by Springer Science and Business Media LLC in Journal of Nanobiotechnology
- Vol. 8 (1), 16
- https://doi.org/10.1186/1477-3155-8-16
Abstract
Background Oxidative stress is imperative for its morbidity towards diabetic complications, where abnormal metabolic milieu as a result of hyperglycemia, leads to the onset of several complications. A biological antioxidant capable of inhibiting oxidative stress mediated diabetic progressions; during hyperglycemia is still the need of the era. The current study was performed to study the effect of biologically synthesized gold nanoparticles (AuNPs) to control the hyperglycemic conditions in streptozotocin induced diabetic mice. Results The profound control of AuNPs over the anti oxidant enzymes such as GSH, SOD, Catalase and GPx in diabetic mice to normal, by inhibition of lipid peroxidation and ROS generation during hyperglycemia evidence their anti-oxidant effect during hyperglycemia. The AuNPs exhibited an insistent control over the blood glucose level, lipids and serum biochemical profiles in diabetic mice near to the control mice provokes their effective role in controlling and increasing the organ functions for better utilization of blood glucose. Histopathological and hematological studies revealed the non-toxic and protective effect of the gold nanoparticles over the vital organs when administered at dosage of 2.5 mg/kilogram.body.weight/day. ICP-MS analysis revealed the biodistribution of gold nanoparticles in the vital organs showing accumulation of AuNPs in the spleen comparatively greater than other organs. Conclusion The results obtained disclose the effectual role of AuNPs as an anti-oxidative agent, by inhibiting the formation of ROS, scavenging free radicals; thus increasing the anti-oxidant defense enzymes and creating a sustained control over hyperglycemic conditions which consequently evoke the potential of AuNPs as an economic therapeutic remedy in diabetic treatments and its complications.Keywords
This publication has 64 references indexed in Scilit:
- Bioaccumulation and toxicity of gold nanoparticles after repeated administration in miceBiochemical and Biophysical Research Communications, 2010
- Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cellsJournal of Nanobiotechnology, 2009
- Assessment of the In Vivo Toxicity of Gold NanoparticlesNanoscale Research Letters, 2009
- Extracellular biosynthesis of silver nanoparticles by the culture supernatant of Bacillus licheniformisMaterials Letters, 2008
- Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveatsNanomedicine, 2008
- Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3Immunology, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunitExperimental & Molecular Medicine, 2003
- Capture of Stealth Nanoparticles by the Body’s DefencesCritical Reviews in Therapeutic Drug Carrier Systems, 2001
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991